The Cigna Group (CI)
319.31 x 4 328.50 x 1
Pre-market by (Cboe BZX)
321.23 +4.39 (+1.39%) 03/26/25 [NYSE]
319.31 x 4 328.50 x 1
Pre-market 321.78 +0.55 (+0.17%) 06:05 ET
for Thu, Mar 27th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,778,000 | 2,242,000 | 1,417,000 | -212,000 | 5,372,000 |
| Depreciation Amortization | 2,775,000 | 2,129,000 | 1,479,000 | 741,000 | 3,035,000 |
| Income taxes - deferred | -95,000 | -351,000 | -199,000 | -102,000 | -1,659,000 |
| Accounts payable and accrued liabilities | 9,895,000 | 8,160,000 | 7,805,000 | 3,569,000 | 5,511,000 |
| Other Working Capital | 1,192,000 | -1,780,000 | 505,000 | 2,558,000 | 3,488,000 |
| Other Operating Activity | -7,182,000 | -5,249,000 | -5,902,000 | -1,714,000 | -3,934,000 |
| Operating Cash Flow | $10,363,000 | $5,151,000 | $5,105,000 | $4,840,000 | $11,813,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,406,000 | -1,069,000 | -670,000 | -300,000 | -1,573,000 |
| Net Acquisitions | 390,000 | -132,000 | N/A | N/A | -434,000 |
| Purchase Of Investment | -2,749,000 | -2,025,000 | -1,410,000 | -806,000 | -5,657,000 |
| Sale Of Investment | 2,635,000 | 1,800,000 | 1,295,000 | 723,000 | 2,822,000 |
| Other Investing Activity | -972,000 | -485,000 | -350,000 | -112,000 | -332,000 |
| Investing Cash Flow | $-2,102,000 | $-1,911,000 | $-1,135,000 | $-495,000 | $-5,174,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -402,000 | 366,000 | -467,000 | -364,000 | 1,198,000 |
| Debt Issued | 4,462,000 | 4,462,000 | 4,462,000 | 4,462,000 | 1,491,000 |
| Debt Repayment | -3,000,000 | -3,000,000 | -3,000,000 | -2,210,000 | -2,967,000 |
| Common Stock Issued | 305,000 | 283,000 | 221,000 | 181,000 | 187,000 |
| Common Stock Repurchased | -7,034,000 | -5,012,000 | -5,012,000 | -4,022,000 | -2,284,000 |
| Dividend Paid | -1,567,000 | -1,183,000 | -793,000 | -401,000 | -1,450,000 |
| Other Financing Activity | -411,000 | -315,000 | -249,000 | -175,000 | -469,000 |
| Financing Cash Flow | $-7,647,000 | $-4,399,000 | $-4,838,000 | $-2,529,000 | $-4,294,000 |
| Exchange Rate Effect | -20,000 | 6,000 | -12,000 | -9,000 | 16,000 |
| Beginning Cash Position | 8,337,000 | 7,088,000 | 8,337,000 | 8,337,000 | 5,976,000 |
| End Cash Position | 8,931,000 | 5,935,000 | 7,457,000 | 10,144,000 | 8,337,000 |
| Net Cash Flow | $594,000 | $-1,153,000 | $-880,000 | $1,807,000 | $2,361,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,363,000 | 5,151,000 | 5,105,000 | 4,840,000 | 11,813,000 |
| Capital Expenditure | -1,406,000 | -1,069,000 | -670,000 | -300,000 | -1,573,000 |
| Free Cash Flow | 8,957,000 | 4,082,000 | 4,435,000 | 4,540,000 | 10,240,000 |